on surrogate endpoints in oncology
Published 2 years ago • 291 plays • Length 19:05Download video MP4
Download video MP3
Similar videos
-
1:06:54
surrogate endpoints in oncology and their role in regulatory approval
-
1:09:38
why oncology needs more common sense and less cheerleading by dr bishal gyawali
-
15:44
assessing the value of cancer drugs
-
1:17:54
is evidence-based medicine being hijacked in oncology?
-
1:20:45
what to look out for when reading a clinical trial report? a primer on critical appraisal skills.
-
1:06:04
a return to common sense in oncology- a combined grand rounds by dr. chris booth& dr. bishal gyawali
-
5:21
innovation and affordability do not go hand in hand
-
4:05
refusing to read, listen or link to something while disagreeing
-
3:30
bishal gyawali oncology in low and high income countries esmo 2016
-
1:17:58
dr. bishal gyawali. is evidence-based medicine being hijacked in oncology? 26.08.2021
-
24:51
esmo 2022 lecture: the role of single-arm trials in oncology
-
53:49
critical appraisal of a clinical trial- lecture by dr. bishal gyawali
-
2:21
is event-free survival a valid surrogate for overall survival in early breast cancer trials?
-
13:18
dr bishal gyawali on the importance of communication skills in oncology
-
1:06:45
optimal clinical trial design with dr. bishal gyawali
-
1:31:47
3.04 listener questions & medtwitter and risk benefit profile of ramucirumab with dr. bishal gyawali
-
52:29
bishal gyawali and nathan cherny on esmo mcbs scores
-
55:22
fda approvals and coi
-
16:04
what patients and advocates should know about cancer clinical trials?
-
2:17
oncology clinical trials: why we're searching for emerging endpoints